BioCentury | Nov 14, 2020
Politics, Policy & Law

Candidates for next FDA commissioner

...Laurie Glimcher, president and CEO of the Dana-Farber Cancer Institute...
...cancer immunologist, in addition to leading the Dana-Farber Cancer Institute...
BioCentury | Jun 27, 2020
Translation in Brief

Regeneron enhances checkpoint therapy with CD28 bispecifics; plus NIH funds Alzheimer’s brain mapping, Genentech and more

...transducer and activator of transcription 3 TEAD - TEA domain family member BioCentury Staff Regeneron Pharmaceuticals Inc. Genentech Inc. Roche Dana-Farber Cancer Institute Allen...
BioCentury | Jun 6, 2020
Translation in Brief

Engineered bacteria for targeted bacterial killing; plus Cas12a base editors, base editing to restore hearing and more

...pancreatic cancer Serial entrepreneur Nathanael Gray and colleagues at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute...
...of Washington University of California San Diego Harvard University Broad Institute of MIT and Harvard Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Duke...
BioCentury | May 22, 2020
Emerging Company Profile

With $60M, Canaan-incubated Day One seizes on under-appreciated advances in pediatric cancers

...Cancer Clinical status: Phase II Founded: 2018 by Julie Grant and Samuel Blackman University collaborators: Dana-Farber Cancer Institute...
BioCentury | May 2, 2020
Management Tracks

Catalent’s Boerman becomes president of cell and gene therapy; plus Stanford, Intellia, Cortexyme, CZ Biohub, Grail and more

...NYSE:JNJ) on Wednesday to manufacture the pharma’s COVID-19 vaccine (see “J&J’s Second Manufacturing Partner” ). Dana-Farber Cancer Institute...
BioCentury | Apr 15, 2020
Emerging Company Profile

Backed by Third Rock-led syndicate, MOMA seeks new ATP-powered targets by interrogating 'molecular machines'

...Rock entrepreneur-in-residence Timur Yusufzai, who joined the firm in 2018 from Harvard Medical School and Dana-Farber Cancer Institute...
BioCentury | Mar 14, 2020
Translation in Brief

A peptide fusion blocker for multiple coronaviruses, the cryo-EM structure of SARS-CoV-2 main protease, plus Locus, Excision and Harvard-Dana-Farber

...Open access algorithm for virtual drug discovery A team led by Harvard University and Dana-Farber Cancer Institute...
...ECH-associated protein 1 NFE2L2 (NRF2) - Nuclear factor (erythroid-derived 2)-like 2 BioCentury Staff Locus Biosciences Inc. Harvard Medical School Dana-Farber Cancer Institute Temple...
BioCentury | Feb 27, 2020
Finance

MPM, Dana-Farber forge philanthropic arrangement around new oncology funds

...With the launch of two new funds, MPM Capital and Dana-Farber Cancer Institute each gain access to more...
...in the environment around tumors, which could help predict responses to immunotherapies. Paul Bonanos, Associate Editor MPM Capital Dana-Farber Cancer Institute...
BioCentury | Feb 7, 2020
Translation in Brief

Gilead’s remdesivir vs. 2019-nCov in cells; plus Syndax, Syntrix and Max Planck

...use against coronavirus (see “O’Day on Remdesivir” ). Syndax’s SNDX-5613 to prevent NPM1-mutant leukemia A Dana-Farber Cancer Institute...
...Myeloid-lymphoid or mixed-lineage leukemia protein NPM1 (B23) - Nucleophosmin BioCentury Staff Max Planck Institute University of Lausanne Syndax Pharmaceuticals Inc. Dana-Farber Cancer Institute Gilead...
BioCentury | Feb 1, 2020
Distillery Therapeutics

CDK7 inhibition for treating small cell lung cancer

...Dana-Farber Cancer Institute, Boston, Mass.; Harvard Medical School, Boston, Mass. email: nathanael_gray@dfci.harvard.edu Claire Quang New York University Langone Medical Center Dana-Farber Cancer Institute Cyclin...
Items per page:
1 - 10 of 634
BioCentury | Nov 14, 2020
Politics, Policy & Law

Candidates for next FDA commissioner

...Laurie Glimcher, president and CEO of the Dana-Farber Cancer Institute...
...cancer immunologist, in addition to leading the Dana-Farber Cancer Institute...
BioCentury | Jun 27, 2020
Translation in Brief

Regeneron enhances checkpoint therapy with CD28 bispecifics; plus NIH funds Alzheimer’s brain mapping, Genentech and more

...transducer and activator of transcription 3 TEAD - TEA domain family member BioCentury Staff Regeneron Pharmaceuticals Inc. Genentech Inc. Roche Dana-Farber Cancer Institute Allen...
BioCentury | Jun 6, 2020
Translation in Brief

Engineered bacteria for targeted bacterial killing; plus Cas12a base editors, base editing to restore hearing and more

...pancreatic cancer Serial entrepreneur Nathanael Gray and colleagues at Beth Israel Deaconess Medical Center and Dana-Farber Cancer Institute...
...of Washington University of California San Diego Harvard University Broad Institute of MIT and Harvard Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Duke...
BioCentury | May 22, 2020
Emerging Company Profile

With $60M, Canaan-incubated Day One seizes on under-appreciated advances in pediatric cancers

...Cancer Clinical status: Phase II Founded: 2018 by Julie Grant and Samuel Blackman University collaborators: Dana-Farber Cancer Institute...
BioCentury | May 2, 2020
Management Tracks

Catalent’s Boerman becomes president of cell and gene therapy; plus Stanford, Intellia, Cortexyme, CZ Biohub, Grail and more

...NYSE:JNJ) on Wednesday to manufacture the pharma’s COVID-19 vaccine (see “J&J’s Second Manufacturing Partner” ). Dana-Farber Cancer Institute...
BioCentury | Apr 15, 2020
Emerging Company Profile

Backed by Third Rock-led syndicate, MOMA seeks new ATP-powered targets by interrogating 'molecular machines'

...Rock entrepreneur-in-residence Timur Yusufzai, who joined the firm in 2018 from Harvard Medical School and Dana-Farber Cancer Institute...
BioCentury | Mar 14, 2020
Translation in Brief

A peptide fusion blocker for multiple coronaviruses, the cryo-EM structure of SARS-CoV-2 main protease, plus Locus, Excision and Harvard-Dana-Farber

...Open access algorithm for virtual drug discovery A team led by Harvard University and Dana-Farber Cancer Institute...
...ECH-associated protein 1 NFE2L2 (NRF2) - Nuclear factor (erythroid-derived 2)-like 2 BioCentury Staff Locus Biosciences Inc. Harvard Medical School Dana-Farber Cancer Institute Temple...
BioCentury | Feb 27, 2020
Finance

MPM, Dana-Farber forge philanthropic arrangement around new oncology funds

...With the launch of two new funds, MPM Capital and Dana-Farber Cancer Institute each gain access to more...
...in the environment around tumors, which could help predict responses to immunotherapies. Paul Bonanos, Associate Editor MPM Capital Dana-Farber Cancer Institute...
BioCentury | Feb 7, 2020
Translation in Brief

Gilead’s remdesivir vs. 2019-nCov in cells; plus Syndax, Syntrix and Max Planck

...use against coronavirus (see “O’Day on Remdesivir” ). Syndax’s SNDX-5613 to prevent NPM1-mutant leukemia A Dana-Farber Cancer Institute...
...Myeloid-lymphoid or mixed-lineage leukemia protein NPM1 (B23) - Nucleophosmin BioCentury Staff Max Planck Institute University of Lausanne Syndax Pharmaceuticals Inc. Dana-Farber Cancer Institute Gilead...
BioCentury | Feb 1, 2020
Distillery Therapeutics

CDK7 inhibition for treating small cell lung cancer

...Dana-Farber Cancer Institute, Boston, Mass.; Harvard Medical School, Boston, Mass. email: nathanael_gray@dfci.harvard.edu Claire Quang New York University Langone Medical Center Dana-Farber Cancer Institute Cyclin...
Items per page:
1 - 10 of 634